Archive: neuroscience
-
Georgetown Physician Leads International Experts in Developing Treatment Guidelines for Huntington’s Disease Symptoms
Category: GUMC Stories
-
Researchers Find Inhibiting One Protein Destroys Toxic Clumps Seen in Parkinson’s Disease
Category: News Release
-
Georgetown Study Investigates Memory Improvement Through Nicotine Dosing
A new study being conducted at Georgetown University Medical Center aims to find out if nicotine can slow or stop memory loss in people experiencing mild memory problems.
Category: News Release
-
Making Sense of Senses: Researchers Find the Brain Processes Sight and Sound in the Same Two-Step Manner
A new study published by senior investigator Maximilian Riesenhuber, PhD, a professor in Georgetown University School of Medicine’s Department of Neuroscience, and fellow Georgetown neuroscientists Xiong Jiang, PhD; Mark A. Chevillet; and Josef P. Rauschecker, PhD, is the first to provide strong evidence that learning in sight and sound follows similar principles.
Category: News Release
-
If Your Child is Bilingual, Learning Additional Languages Later Might be Easier
It is often claimed that bilinguals are better than monolinguals at learning languages. Now, the first study to examine bilingual and monolingual brains as they learn an additional language offers new evidence that supports this hypothesis, researchers say.
Category: News Release
-
Agent Clears Toxic Proteins, Reduces Inflammation and Improves Cognition in Neurodegeneration Models
Category: News Release
-
Georgetown University Licenses Use of Tyrosine Kinase Inhibitors for Treatment of Neurodegenerative Diseases
Georgetown University today announces it has exclusively licensed worldwide intellectual property (IP) rights to develop and commercialize uses of tyrosine kinase (TK) inhibitors for the treatment of neurodegenerative diseases to Axovant Sciences GmbH.
Category: News Release
-
New Clinical Trial Will Test Cancer Drug as Alzheimer's Treatment
The following is a press release issued by the ADDF: NEW YORK (September 29, 2016) – The Alzheimer’s Drug Discovery Foundation (ADDF) announces a $2.1 million grant awarded to R. Scott Turner, MD,
Category: News Release
-
Resveratrol Appears to Restore Blood-Brain Barrier Integrity in Alzheimer’s Disease
Category: News Release
-
Study: Cancer Drug Restores Brain Dopamine, Reduces Toxic Proteins in Parkinson, Dementia
Category: News Release